Try our Advanced Search for more refined results
September 17, 2020
Stachowski v. Boyd et al
Case Number:
3:20-cv-06525
See also:
Court:
Nature of Suit:
Multi Party Litigation:
Derivative Litigation
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 18, 2020
Derivative Suit Says Biotech Co. Lied About COVID-19 Vaccine
An investor of biotechnology company Vaxart has accused the company's officers of enriching themselves and artificially inflating stock prices by lying about receiving government funding to develop a COVID-19 vaccine, according to a shareholder derivative suit filed in California federal court Thursday.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login